Hot topics close
 

Japan Plans Economic Restart; Singapore Easing: Virus Update

(Bloomberg) -- The U.S. Food and Drug Administration cleared Gilead Sciences Inc.’s experimental antiviral drug, remdesivir, for emergency use and Japan began a special approval process for the treatment. It’s the first medication backed by early clin
Similar news
  • Mexico will not follow FDA in approving Gilead's COVID-19 drug
  • Why the approval of remdesivir to treat Covid-19 obscures bigger scientific failures
  • FDA's first COVID-19 treatment Gilead's remdesivir: 5 fast facts
  • FDA Approves First Treatment for COVID-19
  • US FDA Approves Remdesivir as First Drug to Treat Coronavirus
  • US FDA approves use of Gilead's remdesivir for hospitalised coronavirus patients
  • WHO Solidarity trial: Remdesivir has no substantial effect on mortality in COVID-19 patients
  • Post trials' data, need to revise treatment regimen for Covid-19: Experts
  • Trump is taking remdesivir. Here's how it works to control the coronavirus
  • What is remdesivir therapy
  • Gilead Says FDA Could Broaden Remdesivir Use Despite Data; Analyst Slashes PT
  • Virus drug benefit only marginal: study
  • Remdesivir approved by the Therapeutic Goods Administration for severe coronavirus cases
  • New drug to help Australian patients fight off COVID-19 comes with 'caveats'
  • New COVID-19 treatment remdesivir is 'no silver bullet' warns DCMO, as Victorian outbreak worsens
  • Remdesivir 'reduced virus death risk' but more studies needed
  • Coronavirus update: Remdesivir approved as Australia's first COVID-19 treatment only available for severe cases
  • Remdesivir may reduce deaths, appears to work better in certain patients
  • Australia approves Gilead's remdesivir for COVID-19 treatment
  • Remdesivir: Australia's first COVID-19 treatment approved by Therapeutic Goods Administration